Home›Stock Screener›Pfizer

Pfizer Share Price Today | Stock Price & Pfizer Share Screener

PFIZER Pharmaceuticals & Biotechnology
Live Share Price NSE
₹3850.30
▲ 8.50 (0.22%)
2026-11-19 00:00:00
Live Share Price BSE
₹3849.70
▲ 4.90 (0.13%)
2026-11-19 00:00:00

As of November 19, 2026, the live Pfizer share price (NSE: PFIZER) is ₹3,850.30 on NSE and ₹3,849.70 on BSE, up 0.22% from the previous close, with shares trading between ₹3,801.20 and ₹3,859.90 in today's trading session, and a 52-week range of ₹3,612.30–₹5,197.80. Track PFIZER market value to gauge the company's total market size. Use the Pfizer stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Pfizer opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹2,967 and net income of ₹859, with EBITDA of ₹1,227, an operating margin of 34.0% and a profit margin of 29.0%.

Pfizer Market Cap ₹17,575.36 Cr.
PFIZER P/E Ratio (TTM) 20.30
Pfizer P/B Ratio 3.98
EPS (TTM) ₹157.92
Dividend Yield 1.97%
Debt to Equity 0.02
PFIZER 52 Week High ₹5197.80
Pfizer 52 Week Low ₹3612.30
Operating Margin 34.00%
Profit Margin 28.95%
PFIZER Revenue (TTM) ₹2,967.00
EBITDA ₹1,227.00
Net Income ₹859.00
Total Assets ₹4,922.00
Total Equity ₹4,203.00

Pfizer Share Price Chart

Track the current stock price of Pfizer with an interactive chart. Analyse PFIZER share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Pfizer stock quote in one place.

The quote of ₹3,850.30 sits between the 52-week low of ₹3,612.30 and the 52-week high of ₹5,197.80, and the latest session moved 0.22% from the previous close.

Pfizer Company Profile - Fundamental Screener

Screen Pfizer company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PFIZER shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, with Pradip Shah listed as chairperson or CEO, and it trades under ISIN INE182A01018.

Business Overview

Pfizer Limited is an Indian pharmaceutical company engaged in manufacturing, marketing, trading, and exporting pharmaceutical products. It has a manufacturing facility in Goa and works with contract manufacturers across India. The company offers a diverse portfolio of products including vaccines, anti-infectives, cardiac medications, pain relief, maternal nutrition, gastrointestinal treatments, contraceptives,...more

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

Chairperson/CEO Pradip Shah
ISIN INE182A01018

Pfizer Balance Sheet Screener

Screen PFIZER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹4,922, up from ₹4,911 in 2025.

Latest statistics put total assets at ₹4,922 and shareholder funds at ₹4,203, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 4,922 4,911 4,229 4,001 3,901 3,266 4,405 3,940 3,690 3,261
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 678 724 713 749 869 894 973 886 950 902

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 92 124 87 136 183 99 137 37 52 62
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4,203 4,217 3,596 3,207 2,864 2,393 3,396 3,011 2,683 2,419
Share Capital 46 46 46 46 46 46 46 46 46 46
Reserves & Surplus 4,157 4,172 3,550 3,162 2,819 2,347 3,350 2,966 2,637 2,373

Pfizer Income Statement Screener - Profit & Revenue Analysis

Screen Pfizer income statement and profit fundamentals. Analyze PFIZER quarterly results. Pfizer reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹2,967 and net profit was ₹859, equal to earnings per unit of ₹187.80, at an operating margin of 34%.

In that period expenses were ₹1,740, interest cost ₹9 and tax ₹303. The next period listed, 2026-March, shows revenue of ₹2,708 and net profit of ₹722.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 2,967 2,708 2,454 2,374 2,526 2,674 2,320 2,336 2,249 2,083 2,067 2,103 1,921
Expenses 1,740 1,616 1,541 1,558 1,616 1,775 1,526 1,579 1,516 1,468 1,617 1,586 1,470

Operating Costs and Margins

EBITDA 1,227 1,092 913 816 910 898 793 757 733 615 450 517 450
Operating Profit % 34.00% 36.00% 32.00% 29.00% 33.00% 32.00% 32.00% 27.00% 27.00% 25.00% 18.00% 21.00% 21.00%
Depreciation 58 58 61 62 106 115 109 103 71 66 63 124 131
Interest 9 10 8 15 13 11 15 11 1 0 1 1 1

Profit and Earnings

Profit Before Tax 1,160 976 1,016 746 824 773 669 643 660 548 517 402 238
Tax 303 253 249 195 200 160 171 133 231 188 180 179 138
Net Profit 859 722 768 551 624 613 498 509 429 360 337 223 100
EPS 187.80 157.92 167.79 119.22 136.38 133.89 108.77 111.28 93.78 78.70 73.61 66.66 15.26

Pfizer Cash Flow Screener - Liquidity Fundamentals

Screen PFIZER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹968, and net cash flow was an outflow of ₹392.

Over the same period, investing activities used ₹562 and financing activities used ₹798.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 968 660 257 356 667 427 323 98 332 329
Investing Activities -562 -71 54 -36 -575 -469 1,530 35 -238 -250

Financing and Net Cash

Financing Activities -798 -205 -235 -346 -181 -1,571 -164 -110 -110 -83
Net Cash Flow -392 383 75 -26 -88 -1,613 1,690 23 -17 -4

Pfizer Shareholding Pattern Screener

See Pfizer shareholding pattern with promoter, FII, and DII holdings. Check Pfizer promoter holding and ownership changes for PFIZER on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 63.92%, foreign institutions 2.81%, domestic institutions 16.89% and the public 11.87%, spread across 99,545 shareholders.

The shareholder count was 99,545 in 2026-Mar, compared with 102,478 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92%

Institutional Investors

FII Holding 2.81% 1.65% 1.63% 2.18% 2.39% 2.60% 2.71% 3.33%
DII Holding 16.89% 17.80% 17.52% 17.10% 17.23% 17.10% 17.05% 15.33%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 11.87% 12.04% 12.20% 12.34% 12.02% 12.08% 11.93% 12.90%
Other Holding 4.51% 4.59% 4.72% 4.45% 4.43% 4.29% 4.39% 4.52%
Shareholder Count 99,545 102,478 104,472 108,261 103,222 103,480 100,933 109,214

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Pfizer. Pfizer dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹75.00 per unit for 2026-March, a yield of 1.97%, compared with ₹165.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹75.00, ₹165.00 and ₹35.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹75.00 1.97%
2025-March ₹165.00 3.50%
2024-March ₹35.00 0.87%
2023-March ₹40.00 0.95%
2022-March ₹35.00 1.00%
2021-March ₹35.00 0.80%
2020-March ₹330.00 7.29%
2019-March ₹22.50 0.56%
2018-March ₹20.00 0.60%
2017-March ₹20.00 0.92%

Pfizer Stock Index Membership - Nifty & Sensex

See which indices include Pfizer stock. Check PFIZER index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 14 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP

Pfizer Market Events Screener - Corporate Actions

Get Pfizer corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Pfizer stock events that may affect PFIZER share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 3, 2026, with a record date of November 3, 2026.

It is followed by Quarterly Result Announcement dated July 28, 2026 and Annual General Meeting dated July 28, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-03 2026-11-03 Quarterly Result Announcement NA 0.73%
2026-07-28 2026-07-28 Quarterly Result Announcement NA 2.67%
2026-07-28 2026-07-28 Annual General Meeting NA -3.80%
2026-07-17 2026-07-17 Dividend ₹ 75.00 /share -3.64%
2026-05-12 2026-05-12 Quarterly Result Announcement NA 4.09%
2026-02-09 2026-02-09 Quarterly Result Announcement NA -0.19%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -4.06%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.68%
2025-07-21 2025-07-21 Annual General Meeting NA 20.59%
2025-07-09 2025-07-09 Dividend ₹ 35.00 /share 32.64%
2025-07-09 2025-07-09 Dividend ₹ 30.00 /share 32.64%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 3.80%
2025-01-31 2025-01-31 Quarterly Result Announcement NA -5.60%
2024-10-28 2024-10-28 Quarterly Result Announcement NA -6.42%
2024-08-28 2024-08-28 Annual General Meeting NA 0.34%

Pfizer Competitors Screener - Peer Stocks Comparison

Screen PFIZER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,036 40.80 61,674 12.69% 11,565 60.77
Divis Laboratories 293,316 87.70 11,067 13.95% 2,568 65.94
Torrent Pharmaceuticals 175,376 84.70 13,886 20.34% 2,138 42.26
Laurus Labs 125,488 94.90 6,868 22.01% 890 55.82
Zydus Life Science 119,900 27.90 27,658 17.64% 5,026 55.22
Dr Reddys Laboratories 116,705 42.00 35,059 3.90% 4,158 73.09
Cipla 114,474 39.20 29,045 2.24% 3,870 62.07
Mankind Pharma 108,424 47.50 14,636 14.85% 1,938 62.66
Aurobindo Pharma 103,355 25.90 34,145 5.56% 3,503 60.69
Lupin 90,173 17.10 29,039 26.75% 5,356 44.73

Pfizer Company Announcements - News & Reports Screener

Screen PFIZER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 3, 2026.

The next most recent announcements are dated October 26, 2026 and October 9, 2026.

Date Update Actions
2026-11-03 Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026. -
2026-10-26 Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026. -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-29 Closure of Trading Window -
2026-09-29 Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-09-18 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-07 Board Meeting Outcome for Discontinuation Of Minipress XL. -
2026-08-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-07-28 Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2026. -
2026-07-27 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-07-20 Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30 2026. -
2026-07-17 Response To Clarification Sought By BSE Limited. -
2026-07-17 Clarification sought from Pfizer Ltd -
2026-07-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-07 Letter To Shareholders Providing The Weblink To Access The Annual Report For Financial Year 2025-26. -
2026-07-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-06 Shareholders Meeting - AGM Notice -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹3,850.30, within a 52-week range of ₹3,612.30 to ₹5,197.80. The P/E ratio is 20.30 and the P/B ratio is 3.98, with earnings per unit of ₹157.92. Market capitalisation stands at ₹17,575.36 Cr and the dividend yield is 1.97%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.